NLRP12

Chr 19AD

NLR family pyrin domain containing 12

Also known as: CLR19.3, FCAS2, NALP12, PAN6, PYPAF7, RNO, RNO2

The protein functions as a potent anti-inflammatory regulator in immune cells, inhibiting NF-kappaB and ERK signaling pathways and suppressing inflammatory responses in activated monocytes and macrophages. Mutations cause familial cold autoinflammatory syndrome type 2, an inherited autoinflammatory disorder with autosomal dominant inheritance. The gene shows low constraint against loss-of-function variants, suggesting tolerance to complete protein loss.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismADLOEUF 1.351 OMIM phenotype
Clinical SummaryNLRP12
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
4 unique Pathogenic / Likely Pathogenic· 228 VUS of 400 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.35LOEUF
pLI 0.000
Z-score -0.26
OE 1.04 (0.811.35)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-1.71Z-score
OE missense 1.20 (1.121.27)
729 obs / 610.0 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.04 (0.811.35)
00.351.4
Missense OE1.20 (1.121.27)
00.61.4
Synonymous OE1.19
01.21.6
LoF obs/exp: 41 / 39.3Missense obs/exp: 729 / 610.0Syn Z: -2.50
DN
0.6939th %ile
GOF
0.6931th %ile
LOF
0.2386th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function, dominant-negative and loss-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median · 1 literature citation
DNprediction above median
LOF1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFThis study also demonstrates, by means of functional assays, the deleterious effect of this recurrent missense mutation; the gain of function for speck formation and caspase 1 signaling associated with this NBS mutation is consistent with the inflammatory phenotype of PFS.PMID:21538323
LOFIn affected members of 2 unrelated families with familial cold autoinflammatory syndrome-2 (FCAS2; 611762), Jeru et al. (2008) identified heterozygous mutations in the NLRP12 gene (609648.0001 and 609648.0002). The findings indicated a dominant mode of expression through haploinsufficiency.PMID:18230725

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

400 submitted variants in ClinVar

Classification Summary

Pathogenic1
Likely Pathogenic3
VUS228
Likely Benign154
Benign3
Conflicting11
1
Pathogenic
3
Likely Pathogenic
228
VUS
154
Likely Benign
3
Benign
11
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
1
0
1
Likely Pathogenic
3
0
0
0
3
VUS
26
182
17
3
228
Likely Benign
0
1
46
107
154
Benign
0
0
2
1
3
Conflicting
11
Total2918366111400

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

NLRP12 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 5 results · since 2015Search PubMed ↗